Regeneron and Sanofi are back with another push to show how Dupixent can help people with asthma “Du More.” The fourth generation of the campaign dials up the humor to try to connect with ...

The fourth generation of the Dupixent DU More campaign features two video ads that show how ordinary asthma patients are able to enjoy day-to-day activities by breathing better.

Dupixent is an injectable biologic medicine. Here’s how it works for asthma.

The lower efficacy will also be a hit for Sanofi as amlitelimab, an anti-OX40L monoclonal antibody (mAb), had been touted as ...

In another top story, a study found that Dupixent (dupilumab, Regeneron) was more effective in reducing asthma exacerbations, with 0.5 fewer asthma exacerbations per person per 1.5 years compared ...

Dupixent surpassed Xolair in treating CRSwNP and asthma, improving symptoms and quality of life significantly. Quiver AI Summary New findings from the EVEREST Phase 4 trial presented at the 2025 ...